Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | KeraHeal-Allo™ | Company | Biosolution Co., Ltd. |
|---|---|---|---|
| Classification | Cell Therapy product | Active Ingredient | Allogeneic skin-derived keratinocytes |
| Reference Product | Approval Date | 2015 | |
| Indication | Deep second degree burns | ||
| Description |
KeraHeal-Allo™ is a hydrogel-type allogeneic keratinocyte therapy product that has received product approval in 2015 by the MFDS. KeraHeal-Allo™ is composed of allogeneic keratinocytes that promote re-epithelialization by secreting growth factors and cytokines to stimulate the cells around the wound. Keratinocytes are suspended in a thermosensitive hydrogel which transforms into gel from liquid when in contact with body temperature. KeraHeal-Allo™ can be stored at –20℃ for up to 18 months. |
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.